Published in Cancer Res on May 01, 1998
c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol Cell Biol (2003) 1.59
HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells. Cancer Biother Radiopharm (2009) 1.06
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL. J Exp Clin Cancer Res (2012) 0.89
Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development. Br J Cancer (2002) 0.85
Induction of apoptosis in human tumor cells after exposure to Auger electrons: comparison with gamma-ray exposure. Nucl Med Biol (2006) 0.82
Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer. Cell Death Dis (2014) 0.81
Spontaneous and inducible apoptosis in oesophageal adenocarcinoma. Br J Cancer (2001) 0.80
Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer. Radiat Oncol (2015) 0.77
Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy. Br J Cancer (2000) 0.76
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (1996) 10.14
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res (1998) 5.86
The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ (2008) 4.31
Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev (2000) 4.24
scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc Natl Acad Sci U S A (1991) 3.69
Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol (1994) 3.30
Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science (1999) 2.96
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2001) 2.71
The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc Natl Acad Sci U S A (1994) 2.15
Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res (1994) 2.02
Candidate genes for the hypoxic tumor phenotype. Cancer Res (2000) 1.94
Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res (2001) 1.80
Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther (2000) 1.75
Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther (1997) 1.71
Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther (1996) 1.66
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.63
Heat shock protein 72 modulates pathways of stress-induced apoptosis. J Biol Chem (1998) 1.55
p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol Cell Biol (2001) 1.53
Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ (2002) 1.48
Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res (2001) 1.45
Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University. Int J Radiat Oncol Biol Phys (2001) 1.44
The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction. Proc Natl Acad Sci U S A (1996) 1.44
Tumour hypoxia: the picture has changed in the 1990s. Int J Radiat Biol (1994) 1.38
Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res (1996) 1.38
Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis. Gene Ther (2002) 1.37
Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci U S A (1998) 1.24
Increased cytotoxicity of chronic hypoxic cells by molecular inhibition of GRP78 induction. Int J Radiat Oncol Biol Phys (1994) 1.23
Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res (1999) 1.23
Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res (1997) 1.19
Mitogen-activated protein kinase acts as a negative regulator of the heat shock response in NIH3T3 cells. Cancer Res (1995) 1.18
Tumor hypoxia and the cell cycle: implications for malignant progression and response to therapy. Cancer J Sci Am (1998) 1.16
Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. Clin Cancer Res (2000) 1.12
Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer (1997) 1.12
Potassium-channel activation in response to low doses of gamma-irradiation involves reactive oxygen intermediates in nonexcitatory cells. Proc Natl Acad Sci U S A (1993) 1.07
Modulation of c-Myc activity and apoptosis in vivo. Cancer Res (1996) 1.07
Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Int J Radiat Oncol Biol Phys (1998) 1.06
Hypoxic microenvironment within an embryo induces apoptosis and is essential for proper morphological development. Teratology (1999) 1.05
A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy. Oncogene (1999) 1.04
Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells. Prostate (2006) 1.03
p53 mediates apoptosis induced by c-Myc activation in hypoxic or gamma irradiated fibroblasts. Cell Death Differ (1998) 1.03
PHD2 in tumour angiogenesis. Br J Cancer (2010) 1.02
Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells. Int J Radiat Oncol Biol Phys (2000) 1.01
Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration. J Clin Endocrinol Metab (1999) 1.00
The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res (2004) 0.99
Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system. Radiother Oncol (1999) 0.96
Rotenone-induced G2/M cell cycle arrest and apoptosis in a human B lymphoma cell line PW. Biochem Biophys Res Commun (2001) 0.96
The regulation of GRP78 and messenger RNA levels by hypoxia is modulated by protein kinase C activators and inhibitors. Radiat Res (1994) 0.96
The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy. Apoptosis (1999) 0.95
Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. J Clin Endocrinol Metab (2001) 0.95
Highly conserved RNA sequences that are sensors of environmental stress. Mol Cell Biol (1998) 0.95
Two independent pathways of helper activity provided by a single T cell clone. J Immunol (1986) 0.95
Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Radiat Res (1997) 0.94
Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res (1997) 0.93
Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res (1995) 0.92
Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res (1994) 0.91
Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. Int J Radiat Oncol Biol Phys (2001) 0.91
G2/M-phase arrest and death by apoptosis of HL60 cells irradiated with exponentially decreasing low-dose-rate gamma radiation. Radiat Res (1999) 0.90
Chromosomal radiosensitivity at intrachromosomal telomeric sites. Genes Chromosomes Cancer (1993) 0.89
Bcl-2 inhibits apoptosis induced by mitochondrial uncoupling but does not prevent mitochondrial transmembrane depolarization. Exp Cell Res (2001) 0.87
p53 promotes selection for Fas-mediated apoptotic resistance. Cancer Res (2000) 0.87
Association of BCL-2 with membrane hyperpolarization and radioresistance. J Cell Physiol (1996) 0.86
Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin. Cancer Biother Radiopharm (1999) 0.85
Differential expression of protein kinase C epsilon protein in lung cancer cell lines by ionising radiation. Br J Cancer (1992) 0.83
Bcl-2 overexpression results in enhanced capacitative calcium entry and resistance to SKF-96365-induced apoptosis. Cancer Res (2000) 0.83
p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia. Exp Cell Res (2000) 0.83
The use of fluorescence in situ hybridisation combined with premature chromosome condensation for the identification of chromosome damage. Br J Cancer (1991) 0.82
Genetic determinants that influence hypoxia-induced apoptosis. Novartis Found Symp (2001) 0.82
Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts. Cancer Res (1993) 0.81
Acidosis reduces neuronal apoptosis. Neuroreport (1998) 0.81
Regulation of insulin-like growth factor-binding protein 1 by hypoxia and 3',5'-cyclic adenosine monophosphate is additive in HepG2 cells. J Clin Endocrinol Metab (2000) 0.81
Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides. Int J Radiat Oncol Biol Phys (1995) 0.80
Increased radiosensitivity of a subpopulation ot T-lymphocyte progenitors from patients with Fanconi's anemia. Blood (1981) 0.80
Molecular cloning of the breakpoint region on chromosome 6 in cutaneous malignant melanoma: evidence for deletion in the c-myb locus and translocation of a segment of chromosome 12. Oncogene (1989) 0.79
Analysis of HSF-1 phosphorylation in A549 cells treated with a variety of stresses. Int J Hyperthermia (1994) 0.79
Analysis of restriction enzyme-induced chromosomal aberrations by fluorescence in situ hybridization. Environ Mol Mutagen (1993) 0.79
The E6 and E7 genes of human papilloma virus-type 16 protect primary astrocyte cultures from injury. Brain Res (1998) 0.79
Stem cell factor enhances the survival of murine intestinal stem cells after photon irradiation. Radiat Res (1995) 0.78
New directions for radiation biology research in cancer of the uterine cervix. J Natl Cancer Inst Monogr (1996) 0.78
Lymphocyte abnormalities in preleukemia--I. Decreased NK activity, anomalous immunoregulatory cell subsets and deficient EBV receptors. Leuk Res (1983) 0.78
Regulation of insulin-like growth factor-binding protein-1 by nitric oxide under hypoxic conditions. J Clin Endocrinol Metab (2000) 0.78
Mechanism of heat shock protein 72 induction in primary cultured astrocytes after oxygen-glucose deprivation. Neurol Res (1996) 0.77
Modulation of potassium channels by protein tyrosine kinase inhibitors. J Cell Physiol (1994) 0.77
The selective growth of human T lymphocyte colonies from whole blood in a semisolid culture system. Exp Hematol (1981) 0.77
Genetically modified clostridium for gene therapy of tumors. Methods Mol Med (2000) 0.77
Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry. Med Phys (1993) 0.77
Stem cell factor enhances the survival of irradiated human bone marrow maintained in SCID mice. Stem Cells (1994) 0.76
Measurement of the relative proportion of symmetrical and asymmetrical chromosome-type interchanges induced by gamma radiation in human-hamster hybrid cells. Radiat Res (1990) 0.76
Loss of the intrinsic heat resistance of human cells and changes in Mr 70,000 heat shock protein expression in human x hamster hybrids. Cancer Res (1991) 0.76
Cancer therapy and tumor physiology. Science (1998) 0.75
Mycosis fungoides arthropathy. Ann Intern Med (1991) 0.75
Relation of age to lymphocyte radiosensitivity in vitro. Health Phys (1984) 0.75
The changing face of radiation oncology. South Med J (1990) 0.75
Effect of thymopoietin and interleukin 2 on depressed mitogenic responsiveness and colony formation of lymphocytes from patients with preleukemia. Thymus (1986) 0.75